Skip to content

MS Cardiologie

Active
Private limited company (pre-2019)founded 2019active for 7 yearsRue Trixhelette(BOD) 39, 4537 Verlaine, BelgiumKBO/BCE: BE 0723.716.604
Summary

MS Cardiologie has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €163,215 and a net result of €150,815. Equity has been growing by about 26% per year since 2019. The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 28-03-2019 Normal situation
Activity
No activity registered in the KBO
Establishment unit
2.290.171.087 4537 Verlaine, since 28-03-2019
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Board and ownership

Board
  • MARCHETTA StellaDirector · since 28-03-2019
  • Moutschen LudovicDirector · since 13-06-2025

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€229,061
▲ 18.0%
Turnover
≈ €570,000
estimated
Profit
€150,815
▲ 11.1%
Equity
€163,215
▼ 55.1%
Total assets
€585,809
▲ 6.8%
  • 2025 accounts filed 31 days after the deadline
Score breakdownraises riskLast filed accounts filed 31 days late; 1 of the last 3 accounts latelowers riskSize: total assets €585,809Liquidity: current ratio 1.32, cash €464,571No main activity registeredShow the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 47% of micro companies without a NACE code
Financial strength · tick: 2024
Strong
Solvency 53-38
equity 27.9% of total assets
Liquidity 61-24
short-term debt 72.1% · cash 79.3%
Profitability 100=
return on assets 25.7%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.2%▲ +0.1 percentage points vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025highest value 07-2025: < 0.1%▼ -0.2 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: 0.1%▼ -0.1 percentage points vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €14,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.32 (2.76 in 2024), below the usual 1.5. Short-term debt is 72.1% and cash 79.3% of total assets. 72.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 32% of them on solvency, 58% on liquidity, 90% on profitability and 9% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €585,809
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Last filed accounts filed 31 days late; 1 of the last 3 accounts late
NBB · filings
lowers risk · Liquidity: current ratio 1.32, cash €464,571
NBB · annual accounts
lowers risk · No main activity registered
KBO
neutral · A punctual record breaks
This company filed 3 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 7 filings
Deviation from the deadline
2025
31 days late
2024
16 days early
2023
44 days early
2022
6 days early
2021
25 days late
2020
20 days late
2019
14 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 7 accounts on average 3 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 July (5 of the last 5 accounts filed within 37 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Equity fell in 2025from €363,673 to €163,215 ▼ 55.1% View
  • Positive: 7 profitable years in a rowprofit 2025: €150,815 7 years View

Recent changes

  1. · Gazette deed Reappointment: Moutschen Ludovic (director)
  2. · Gazette deed Registered office moved from Seraing to VerlaineNew seat: Rue Trixhelette 39 à 4537 Verlaine · Previous seat: Rue Fivé 208 à 4100 Seraing
  3. · Gazette deed Incorporation
All 13 events

Key facts about MS Cardiologie

What is the company number of MS Cardiologie?
The company number of MS Cardiologie is 0723.716.604. The VAT number is the same number with BE in front: BE 0723.716.604.
Where is MS Cardiologie based?
The registered office is at Rue Trixhelette(BOD) 39, 4537 Verlaine.Company details
What is the legal form of MS Cardiologie?
The legal form of MS Cardiologie is Private limited company (pre-2019) (BVBA).
When was MS Cardiologie founded?
MS Cardiologie was founded on 28-03-2019.
Is MS Cardiologie still active?
Yes, MS Cardiologie is an active enterprise in the KBO register.
What is the turnover of MS Cardiologie?
The turnover in financial year 2025 is ≈ €570,000. This figure is estimated from the gross margin of €229,061 and 2,215 comparable companies of the same size. It probably lies between €380,000 and €890,000. It is a rough estimate.Financials
Is MS Cardiologie profitable?
In financial year 2025, MS Cardiologie made a profit of €150,815.
Where can I find the annual accounts of MS Cardiologie?
MS Cardiologie filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MS Cardiologie due?
MS Cardiologie must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.